GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

BioShares Biotechnology Clinical Trials ETF Price (Quote)

$24.71
-0.770 (-3.02%)
At Close: Apr 19, 2024

Range Low Price High Price Comment
30 days $24.57 $29.63 Friday, 19th Apr 2024 BBC stock ended at $24.71. This is 3.02% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.15% from a day low at $24.57 to a day high of $25.59.
90 days $24.09 $31.99
52 weeks $16.88 $31.99

Historical BioShares Biotechnology Clinical Trials Fund prices

Date Open High Low Close Volume
2024-03-14 $29.66 $29.68 $28.47 $28.60 5 421
2024-03-13 $29.24 $29.85 $29.24 $29.85 3 896
2024-03-12 $29.68 $29.68 $29.27 $29.35 3 768
2024-03-11 $30.15 $30.43 $29.52 $29.60 8 062
2024-03-08 $30.87 $31.20 $30.42 $30.43 3 391
2024-03-07 $31.37 $31.37 $30.48 $30.48 10 925
2024-03-06 $30.84 $31.10 $30.84 $31.08 4 202
2024-03-05 $31.15 $31.24 $30.60 $30.61 3 498
2024-03-04 $31.99 $31.99 $30.41 $30.94 20 818
2024-03-01 $30.51 $31.48 $30.51 $31.35 10 289
2024-02-29 $31.17 $31.17 $30.09 $30.09 1 847
2024-02-28 $31.21 $31.30 $30.57 $30.76 10 030
2024-02-27 $29.75 $30.66 $29.75 $30.66 7 353
2024-02-26 $28.60 $29.30 $28.60 $29.30 2 520
2024-02-23 $28.36 $28.56 $28.36 $28.40 7 023
2024-02-22 $28.34 $28.51 $28.34 $28.51 1 496
2024-02-21 $27.54 $27.56 $27.54 $27.56 350
2024-02-20 $28.34 $28.34 $27.65 $27.66 2 485
2024-02-16 $28.34 $28.72 $28.34 $28.72 422
2024-02-15 $28.00 $28.00 $27.97 $27.98 1 300
2024-02-14 $27.34 $27.82 $27.34 $27.72 2 539
2024-02-13 $27.14 $27.20 $27.10 $27.10 2 025
2024-02-12 $27.66 $28.36 $27.66 $28.33 3 568
2024-02-09 $27.24 $27.61 $27.24 $27.61 922
2024-02-08 $26.72 $26.72 $26.72 $26.72 681
Click to get the best stock tips daily for free!

About BioShares Biotechnology Clinical Trials Fund

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its total assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead ... BBC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT